Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems

Bibliography

• Mulligan RC. The basic science of gene therapy. Science 1993;260(5110):926
   Google Scholar
• Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995;6(9):1129-44
   PubMed Web of Science ®Google Scholar
• Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther 2000;7:31-4
   PubMed Web of Science ®Google Scholar
• Lam PY, Breakefield XO. Hybrid vector designs to control the delivery, fate and expression of transgenes. J Gene Med 2000;2(6):395-408
   PubMed Web of Science ®Google Scholar
• Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Ann Rev Biochem 2005;74:711-38
   PubMed Web of Science ®Google Scholar
• Wattiaux R, Laurent N, Wattiaux-De Coninck S, et al. Endosomes, lysosomes: their implication in gene transfer. Adv Drug Deliv Rev 2000;41(2):201-8
   PubMed Web of Science ®Google Scholar
• Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 2005;280(13):12255-61
   PubMed Web of Science ®Google Scholar
• Kaneda, Y. Biological barriers to gene therapy. In: Amiji M, editor. Polymeric Gene Delivery. Florida: CRC Press; 2005. p. 29-42
   Google Scholar
• Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995;1235(2):289-95
   PubMed Web of Science ®Google Scholar
• El Ouahabi A, Thiry M, Pector V, et al. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett 1997;414(2):187-92
   PubMed Web of Science ®Google Scholar
• Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly (ethylene imine) and its derivatives. J Gene Med 2005;7(8):992-1009
   PubMed Web of Science ®Google Scholar
• Seth P. Mechanism of adenovirus-mediated endosome lysis: role of the intact adenovirus capsid structure. Biochem Biophys Res Commun 1994;205(2):1318-24
   PubMed Web of Science ®Google Scholar
• Greber UF, Webster P, Weber J, et al. The role of the adenovirus protease on virus entry into cells. EMBO J 1996;15:1766-77
   PubMed Web of Science ®Google Scholar
• Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999;96:91-6
   PubMed Web of Science ®Google Scholar
• Subramanian A, Ranganathan P, Diamond SL. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotech 1999;17:873-7
   PubMed Web of Science ®Google Scholar
• Ma H, Zhu J, Maronski M, et al. Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell lines. Neuroscience 2002;112(1):1-5
   PubMed Web of Science ®Google Scholar
• Dean DA. Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res 1997;230:293-302
   PubMed Web of Science ®Google Scholar
• Wilson GL, Dean BS, Wang G, et al. Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and specific DNA sequences. J Biol Chem 1999;274(31):22025-32
   PubMed Web of Science ®Google Scholar
• Izaurralde E, Kann M, Pante N, et al. EMBO Workshop Report Viruses, microorganisms and scientists meet the nuclear pore Leysin, VD, Switzerland, February 26 – March 1, 1998. EMBO J 1999;18(2):289-96
   PubMedGoogle Scholar
• Kaneda Y, Tabata Y. Non-viral vectors for cancer therapy. Cancer Sci 2006;97(5):348-54
   PubMed Web of Science ®Google Scholar
• Wagner E, Plank C, Zatloukal K, et al. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin–polylysine–DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 1992;89:7934-8
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989;243:375-8
   PubMed Web of Science ®Google Scholar
• Saeki Y, Matsumoto N, Nakano Y, et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997;8(17):2133-41
   PubMed Web of Science ®Google Scholar
• Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993;221:18-41
   PubMed Web of Science ®Google Scholar
• Kido H, Yokogoshi Y, Sakai K, et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 1992;267(19):13573-9
   PubMed Web of Science ®Google Scholar
• Gotoh B, Ogasawara T, Toyoda T, et al. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J 1990;9(4):4189-95
   PubMed Web of Science ®Google Scholar
• Maeda T, Ohnishi S. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett 1980;122(2):283-7
   PubMed Web of Science ®Google Scholar
• Blumenthal R, Bali-Puri A, Walter A, et al. pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. J Biol Chem 1987;262(28):13614-9
   PubMed Web of Science ®Google Scholar
• Marsh M, Bolzau E, Helenius A. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 1983;32(3):931-40
   PubMed Web of Science ®Google Scholar
• Suvanasuthi S, Tamai K, Kaneda Y. Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector. J Gene Med 2007;9:55-62
   PubMed Web of Science ®Google Scholar
• Cole GA. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. J Immunol 1997;158(9):4301-9
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Nakajima T, Nishikawa T, et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002;6():219-26
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Yamamoto S, Nakajima T. Development of HVJ envelope vector and its application to gene therapy. In: Huang L, Hung M-C, Wagner E, editors. Non-Viral Vectors for Gene Therapy. Elsevier Academic Press; 2005. p. 307-32
   Google Scholar
• Oldfield EH, Ram Z, Culver KW, et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69
   PubMed Web of Science ®Google Scholar
• Oshima K, Shimamura M, Mizuno S, et al. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 2004;18:212-4
   PubMed Web of Science ®Google Scholar
• Shimamura M, Morishita R, Endoh M, et al. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun 2003;300(2):464-71
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342(6248):440-3
   PubMed Web of Science ®Google Scholar
• Honda S, Kagoshima M, Wanaka A, et al. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 1995;32(2):197-210
   PubMedGoogle Scholar
• Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999;2:213-7
   PubMed Web of Science ®Google Scholar
• Shimamura M, Sato N, Ogihara T, et al. A novel therapeutic strategy to treat brain ischemia: over-expression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004;109:424-31
   PubMed Web of Science ®Google Scholar
• Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004;3(4):318-29
   PubMed Web of Science ®Google Scholar
• Sioud M. Ribozyme-and siRNA-mediated mRNA degradation: a general introduction. Methods Mol Biol 2004;252:1-8
   PubMedGoogle Scholar
• Roberts JJ, Kotsaki-Kovatsi VP. Potentiation of sulphur mustard or cisplatin-induced toxicity by caffeine in Chinese hamster cells correlates with formation of DNA double-strand breaks during replication on a damaged template. Mutat Res 1986;165(3):207-20
   PubMed Web of Science ®Google Scholar
• Zdraveski ZZ, Mello JA, Marinus MG, et al. Multiple pathways of recombination define cellular responses to cisplatin. Chem Biol 2000;7:39-50
   PubMed Web of Science ®Google Scholar
• D'Andrea AD, Grompe M. The Fanconi anemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34
   PubMed Web of Science ®Google Scholar
• Ito M, Yamamoto S, Nimura K, et al. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J Gene Med 2005;7:1044-52
   PubMed Web of Science ®Google Scholar
• Morishita R, Gibbons GH, Horiuchi M, et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 1995;92(13):5855-9
   PubMed Web of Science ®Google Scholar
• Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element “decoy” against NF-κB binding site prevented myocardial infarction as gene therapy. Nat Med 1997;3:894-9
   PubMed Web of Science ®Google Scholar
• Nakamura H, Aoki M, Tamai K, et al. Prevention and regeneration of atopic dermatitis by ointment containing NF-κB decoy oligonucleotides in NC/Nga atopic mouse model. Gene Ther 2002;9:1221-9
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347(6):417-29
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3(7):521-33
   PubMed Web of Science ®Google Scholar
• Fichtner-Feigl S, Fuss IJ, Preiss JC, et al. Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides. J Clin Invest 2005;115(11):3057-71
   PubMed Web of Science ®Google Scholar
• Fichter-Feiql S, Strober W, Kawakami K, et al. IL-13 signaling through the IL-13 alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006;12:99-106
   PubMed Web of Science ®Google Scholar
• Yasuoka E, Oshima K, Tamai K, et al. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. J Mol Med 2007;85:279-88
   Web of Science ®Google Scholar
• Takata K, Kitamura Y, Yanagisawa D, et al. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats. FEBS Lett 2007;581:475-8
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Nakagami H, Matsuki A, et al. Development of high-throughput functional screening of therapeutic genes using a hemagglutinating virus of Japan envelope vector. Hum Gene Ther 2006;17:470-5
   PubMed Web of Science ®Google Scholar
• Kitamura T, Koshino Y, Shibata F, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003;31(11):1007-14
   PubMed Web of Science ®Google Scholar
• Scobar NM, Haupt S, Thow G, et al. High-throughput viral expression of cDNA-green fluorescent protein fusions reveals novel subcellular addresses and identifies unique proteins that interact with plasmodesmata. Plant Cell 2003;15:1507-23
   PubMed Web of Science ®Google Scholar
• Saito Y, Nakagami H, Kurooka M, et al. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element. Oncogene; In Press
   Google Scholar
• Kurooka M, Kaneda Y. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res 2007;67:227
   PubMed Web of Science ®Google Scholar
• Fujihara A, Kurooka M, Miki T, et al. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunol Immunother; In Press
   Google Scholar
• Kawano H, Komaba S, Yamasaki T, et al. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. Cancer Chemother Pharmacol; In Press 2007
   Google Scholar
• Marshall E. Clinical trials: gene therapy death prompts review of adenovirus vector. Science 1999;286(5448):2244
   PubMed Web of Science ®Google Scholar
• Kaiser J. Gene therapy: seeking the cause of induced leukemias in X-SCID trial. Science 2003;299:495
   PubMed Web of Science ®Google Scholar
• Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Am Heart Assoc 2002;90:966-73
   Google Scholar
• Blattman JN, Greenberg PD. Cancer Immunotherapy: A Treatment for the Masses. Volume 305. American Association for the Advancement of Science; 2004. p. 200-5
   Google Scholar
• Ahmad M, Rees RC, Ali SA. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother 2004;53(10):844-54
   PubMed Web of Science ®Google Scholar
• Pawelec G. Immunotherapy and immunoselection: tumour escape as the final hurdle. FEBS Lett 2004;567(1):63-6
   PubMed Web of Science ®Google Scholar
• Tomasi TB, Magner WJ, Khan ANH. Epigenetic regulation of immune escape genes in cancer. Cancer Immunol Immunother 2006;55(10):1159-84
   PubMed Web of Science ®Google Scholar
• Banat GA, Christ O, Cochlovius B, et al. Tumour-induced suppression of immune response and its correction. Cancer Immunol Immunother 2001;49(11):573-86
   PubMed Web of Science ®Google Scholar
• Cui Z, Han SJ, Vangasseri DP, Huang L. Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Mol Pharm 2005;2(1):22-8
   PubMed Web of Science ®Google Scholar
• Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006;5(6):471-84
   PubMed Web of Science ®Google Scholar
• Kawano H, Komaba S, Kanamori T, et al. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy. BMC Med 2007;5:28
   PubMedGoogle Scholar
• Mima H, Tomoshige R, Kanamori T, et al. Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector. J Gene Med 2005;7:888-97
   PubMed Web of Science ®Google Scholar
• Mima H, Yamamoto S, Ito M, et al. Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector. Mol Cancer Ther 2006;5:1021-8
   PubMed Web of Science ®Google Scholar
• Kawachi M, Tamai K, Saga K, et al. Development of tissue-targeting HVJ envelope vector for successful delivery of therapeutic gene to mouse skin. Hum Gene Ther 2007;18:881-94
   PubMed Web of Science ®Google Scholar
• Saga K, Tamai K, Kawachi M, et al. Functional modification of Sendai virus by siRNA. J Biotechnol; In Press
   Google Scholar
• Shimbo T, Kawachi M, Saga K, et al. Development of a transferrin receptor-targeting HVJ-E vector. Biochem Biophys Res Commun; 2007;364(3):423-8
   Google Scholar
• Slobod KS, Shenep JL, Lujan-Zilbermann J, et al. Safety and immunogenicity of intranasal murine parainfluenza virus type I (Sendai virus) in healthy human adults. Vaccine 2004;22:3182-6
   PubMed Web of Science ®Google Scholar